Sign in / Join Now
ETFs & Funds
) may be the innovation that brings us one giant step closer to a cure for all cancers!
Add a reply...
Latest StockTalks »
people get SGEN breaking news and analysis by email alert.
Get email alerts on SGEN »
Seattle Genetics, Inc.
Get latest price
From other sites
Seattle Genetics And Takeda Complete Enrollment Of Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) In Frontline Mature T-cell Lymphoma
at TheStreet (Nov 8, 2016)
Seattle Genetics Announces ASH 2016 Abstracts Highlighting Company's Expanding Global Leadership In The Development Of Innovative Antibody-Drug Conjugates
at TheStreet (Nov 3, 2016)
Seattle Genetics (SGEN) Loss Narrower Than Expected In Q3
at TalkMarkets (Oct 29, 2016)
Seattle Genetics (SGEN) Loss Narrower than Expected in Q3
at Zacks.com (Oct 28, 2016)
Seattle Genetics Reports Third Quarter 2016 Financial Results
at TheStreet (Oct 27, 2016)